HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduction in adiposity, β-cell function, insulin sensitivity, and cardiovascular risk factors: a prospective study among Japanese with obesity.

AbstractBACKGROUND:
A reduction in adiposity may be associated with an improvement in insulin sensitivity and β-cell function as well as cardiovascular disease (CVD) risk factors; however, few studies have investigated these associations in a longitudinal setting.
METHODS:
To investigate these associations over a 1-year period, we conducted an observational analysis of 196 Japanese subjects with obesity in the Saku Control Obesity Program. We investigated the relations between changes in adiposity (body mass index [BMI], waist circumference, subcutaneous fat area [SFAT], and visceral fat area [VFAT]) and changes in HbA1c, fasting plasma glucose (FPG), insulin sensitivity index (ISI), the homeostasis model assessment β cell function (HOMA-β), lipids, and blood pressure.
RESULTS:
All adiposity changes were positively associated with HbA1c and FPG changes. Reductions in BMI and VFAT were associated with HOMA-β reduction. Reductions in all adiposity measures were associated with an improvement in the ISI. Changes in most adiposity measures were positively associated with changes in blood pressure and lipid levels, except for LDL.
CONCLUSION:
The present findings provide additional supportive evidence indicating that a reduction in adiposity may lead to an improvement in insulin sensitivity and the reduction of CVD risk factors in obese individuals.
AuthorsMaki Goto, Akemi Morita, Atsushi Goto, Kijo Deura, Satoshi Sasaki, Naomi Aiba, Takuro Shimbo, Yasuo Terauchi, Motohiko Miyachi, Mitsuhiko Noda, Shaw Watanabe, SCOP Study Group
JournalPloS one (PLoS One) Vol. 8 Issue 3 Pg. e57964 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23483954 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • Insulin
  • Lipids
Topics
  • Adiposity
  • Adult
  • Asian People
  • Blood Glucose (metabolism)
  • Blood Pressure
  • Cardiovascular Diseases (blood, complications, epidemiology, physiopathology)
  • Female
  • Humans
  • Insulin (blood)
  • Insulin Resistance
  • Insulin-Secreting Cells (metabolism, pathology)
  • Japan (epidemiology)
  • Lipids (blood)
  • Male
  • Middle Aged
  • Obesity (blood, complications, pathology, physiopathology)
  • Prospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: